Frontiers in Oncology (Mar 2021)

Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis

  • Qitong Chen,
  • Dengjie Ouyang,
  • Dengjie Ouyang,
  • Munawar Anwar,
  • Ning Xie,
  • Shouman Wang,
  • Peizhi Fan,
  • Liyuan Qian,
  • Gannong Chen,
  • Enxiang Zhou,
  • Lei Guo,
  • Xiaowen Gu,
  • Boni Ding,
  • Xiaohong Yang,
  • Liping Liu,
  • Chao Deng,
  • Zhi Xiao,
  • Jing Li,
  • Yunqi Wang,
  • Shan Zeng,
  • Jinhui Hu,
  • Wei Zhou,
  • Bo Qiu,
  • Zhongming Wang,
  • Jie Weng,
  • Mingwen Liu,
  • Yi Li,
  • Tiegang Tang,
  • Jianguo Wang,
  • Hui Zhang,
  • Bin Dai,
  • Wuping Tang,
  • Tao Wu,
  • Maoliang Xiao,
  • Xiantao Li,
  • Hailong Liu,
  • Lai Li,
  • Wenjun Yi,
  • Quchang Ouyang

DOI
https://doi.org/10.3389/fonc.2021.661128
Journal volume & issue
Vol. 11

Abstract

Read online

No abstracts available.

Keywords